• Zealand Pharma EPS for the quarter ending June 30, 2024 was $-0.67, a 16.17% decline year-over-year.
• Zealand Pharma 2023 annual EPS was $-1.81, a 50.98% decline from 2022.
• Zealand Pharma 2022 annual EPS was $-3.68, a 2.51% decline from 2021.
• Zealand Pharma 2021 annual EPS was $-3.78, a 11.77% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.